1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
982.22 -15.37 (-1.54%)
57.46% Gain from 52W Low
2.6M
XNYS Volume

XNYS 09 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Coverage Boost
Eli Lilly’s Mounjaro to be added to China’s national insurance scheme, improving affordable access See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
30.3 / 100
Momentum Score
Technically Moderately Bullish
60.7 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
1,064
1Yr Price target upside is 8%
27 analysts

16

S

10

W

5

O

1

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..